학술논문
Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19.
Document Type
Article
Author
Graziani, Lucia; Gori, Leonardo; Manciulli, Tommaso; Basile, Gregorio; Campolmi, Irene; Borchi, Beatrice; Dio, Marta di; Mattei, Marta; Ciurleo, Greta; Ciliberti, Maria; Malentacchi, Francesca; Coppi, Marco; Morettini, Alessandro; Parronchi, Paola; Rossolini, Gian Maria; Bartoloni, Alessandro; Tomassetti, Sara; Spinicci, Michele
Source
Subject
*RITONAVIR
*COVID-19
*IMMUNOCOMPROMISED patients
*
*
Language
ISSN
0305-7453
Abstract
Follow up CT scan performed 1 month after treatment conclusion showed complete resolution of GGOs in Patient 1 and Patient 3, and significant improvement in Patient 2. In immunocompromised hosts, coronavirus disease 2019 (COVID-19) can span from asymptomatic to severe life-threatening disease. Patient 1 A 62-year-old Caucasian male with non-Hodgkin lymphoma on anti-CD20 therapy with obinutuzumab developed mild SARS-CoV-2 infection in December 2021, reporting fever, cough and myalgia. [Extracted from the article]